Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Revvity
NYSE:RVTY Community
1
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Create a narrative
Revvity
Popular
Undervalued
Overvalued
Revvity
WA
Analyst Price Target
Consensus Narrative from 18 Analysts
Operational Improvements And AI Applications In Diagnostics Will Drive Future Efficiencies
Key Takeaways Operational improvements and AI-driven solutions are poised to enhance workflow efficiencies and drive future revenue growth. Share repurchase authorization and strategic innovations suggest strong cash flow and potential EPS growth.
View narrative
US$136.75
FV
16.8% undervalued
intrinsic discount
5.78%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
RVTY
Revvity
Your Fair Value
US$
Current Price
US$113.84
2.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.5b
Earnings US$362.3m
Advanced
Set as Fair Value